G
Girish Venkataraman
Researcher at University of Chicago
Publications - Â 92
Citations - Â 2266
Girish Venkataraman is an academic researcher from University of Chicago. The author has contributed to research in topics: Lymphoma & Medicine. The author has an hindex of 23, co-authored 77 publications receiving 1907 citations. Previous affiliations of Girish Venkataraman include Loyola University Medical Center & Loyola University Chicago.
Papers
More filters
Journal ArticleDOI
EBV positive mucocutaneous ulcer--a study of 26 cases associated with various sources of immunosuppression
TL;DR: EBV-positive mucocutaneous ulcer is proposed as a newly recognized clinicopathologic entity with Hodgkin-like features and a self-limited, indolent course, generally responding well to conservative management.
Journal ArticleDOI
Age-related EBV-associated lymphoproliferative disorders in the Western population: a spectrum of reactive lymphoid hyperplasia and lymphoma
Stefan Dojcinov,Girish Venkataraman,Stefania Pittaluga,Iwona Wlodarska,Jeffrey A. Schrager,Mark Raffeld,Robert Kerrin Hills,Elaine S. Jaffe +7 more
TL;DR: Age-related EBV(+) B-cell LPD encompasses a wider disease spectrum than previously recognized and includes both reactive and neoplastic conditions and reduction in the T-cell repertoire may contribute to decreased immune surveillance.
Journal ArticleDOI
Clonal evolution underlying leukemia progression and Richter transformation in patients with ibrutinib-relapsed CLL.
Sabah Kadri,Jimmy Lee,Carrie Fitzpatrick,Natalie Galanina,Madina Sukhanova,Girish Venkataraman,Shruti Sharma,Brad Long,Kristin Petras,Megan Theissen,Mei Ming,Yuri Kobzev,Wenjun Kang,Ailin Guo,Weige Wang,Nifang Niu,Howard L. Weiner,Michael J. Thirman,Wendy Stock,Sonali M. Smith,Chadi Nabhan,Jeremy P. Segal,Pin Lu,Y. Lynn Wang +23 more
TL;DR: In patients who had Richter transformation, it is found that the transformed cells were clonal descendants of circulating leukemia cells but continued to undergo evolution and drifts, and transformed lymphoma cells in tissue may acquire a different BTK mutation from that in the CLL leukemia cells.
Journal ArticleDOI
Peripheral T-cell lymphomas of follicular T-helper cell derivation with Hodgkin/Reed-Sternberg cells of B-cell lineage: both EBV-positive and EBV-negative variants exist.
Alina Nicolae,Stefania Pittaluga,Girish Venkataraman,Anahi Vijnovich-Baron,Liqiang Xi,Mark Raffeld,Elaine S. Jaffe +6 more
TL;DR: The close interaction between the HRS-like cells and the rosetting PD-1-positive T cells suggests a possible pathogenetic role in this phenomenon and provides new insights into the abnormal B-cell proliferations that occur in the context of TFH malignancies.
Journal ArticleDOI
PD-L1 gene alterations identify a subset of diffuse large B-cell lymphoma harboring a T-cell-inflamed phenotype.
James Godfrey,Sravya Tumuluru,Riyue Bao,Michael J. Leukam,Girish Venkataraman,John Phillip,Carrie Fitzpatrick,James McElherne,Brendan W. MacNabb,Robert Orlowski,Sonali M. Smith,Justin Kline +11 more
TL;DR: Results indicate that PD-L1 alterations identify a unique biological subset of DLBCL in which an endogenous antilymphoma immune response has been activated, and that is associated with responsiveness to PD-1 blockade therapy.